Emerging Infections 10 - Grand Format

Edition en anglais

W. Michael Scheld

,

James M Hughes

Richard-J Whitley

(Directeur de publication)

,

Collectif

Note moyenne 
Incidents such as the Ebola epidemic in West Africa and the outbreak of Zika in Brazil provide dramatic evidence of the continued ability of microbes... Lire la suite
153,50 € Neuf
Expédié sous 6 à 12 jours
Livré chez vous entre le 4 mai et le 11 mai
En librairie

Résumé

Incidents such as the Ebola epidemic in West Africa and the outbreak of Zika in Brazil provide dramatic evidence of the continued ability of microbes to emerge, spread, adapt, and threaten global health. The challenge facing infectious disease specialists and public health professionals is to improve and find new diagnostic, therapeutic, and prevention strategies. The editors of the 10th installment of the Emerging Infections series have compiled the perspectives of leading infectious disease experts into 22 chapters that provide important updates on a broad range of emerging and reemerging bacterial, viral, parasitic, and fungal infectious diseases in the United States and globally.
In addition to focusing on MERS, Ebola virus disease, chikungunya, and Zika virus disease, Emerging Infections 10 explores the global threat of antimicrobial resistance in reviews on carbapenem-resistant Enterobacteriaceae, multiply-resistant gonococcal infections, non-typhoidal Salmonella infections, and artemisinin-resistant Plasmodium falciparum malaria. Topics include both recently and long-recognized diseases that pose challenges for the clinical, laboratory, research, public health, and animal health communities.
Emerging Infections 10 presents new and emerging strategies to prevent, control, and eradicate infectious diseases and guides readers to the primary literature where they can explore individual topics in greater depth. This book is a valuable reference for professionals in microbiology, epidemiology, public health, and clinical and veterinary medicine.

Caractéristiques

  • Date de parution
    26/07/2016
  • Editeur
  • ISBN
    978-1-55581-944-6
  • EAN
    9781555819446
  • Format
    Grand Format
  • Présentation
    Relié
  • Nb. de pages
    441 pages
  • Poids
    1.145 Kg
  • Dimensions
    17,8 cm × 26,0 cm × 2,5 cm

Avis libraires et clients

Avis audio

Écoutez ce qu'en disent nos libraires !

À propos des auteurs

W. Michael Scheld, MD, is the Bayer-Gerald Mandell Professor of Infectious Diseases, Professor of Medicine, Clinical Professor of Neurosurgery, and Director of the Center for Global Health at the University of Virginia School of Medicine. Dr. Scheld's research includes the molecular pathogenesis and pathophysiology of bacterial infections, anti-inflammatory mechanisms of adenosine receptor subtype agonists and antagonists, antimicrobial resistance, sepsis and septic shock, anthrax, and international health issues including HIV/AIDS in Africa.
James M. Hughes, MD, is Professor of Medecine and Public Health with joint appointments in the School of Medicine (Infectious Diseases) and the Rollins School of Public Health (Global Health) at Emory University and Co-Director of the Emory Antibiotic Resistance Center. Dr. Hughes' research includes emerging and reemerging infectious diseases ; antimicrobial resistance ; healthcare-associated infections ; vectorborne and zoonotic diseases ; foodborne and waterborne diseases ; vaccine-preventable diseases ; rapid detection of and response to infectious diseases and bioterrorism ; and strategies for strengthening public health rapacity at the local, national, and global levels.
Richard J. Whitley, MD, is a Distinguished Professor of Pediatrics, Professor of Microbiology, Medicine and Neurosurgery ; Loeb Eminent Scholar Chair in Pediatrics ; Co-Director, Division of Pediatric Infectious Diseases ; Vice-Chair, Department of Pediatrics ; Cancer Research and Training Center ; Faculty, Gene Therapy Center, and Associate Director for Drug Discovery, Comprehensive Cancer Center at the University of Alabama at Birmingham School of Medicine.
He is also Director, Alabama Drug Discovery Alliance, and is responsible for the National Institute of Allergy and Infectious Disease Collaborative Antiviral Study Group. Dr. Whitley studies the translation of molecular biology to clinical application, particularly the engineering of herpes simplex virus for gene therapy.

Vous aimerez aussi

Derniers produits consultés

153,50 €